NDC product
Potassium Citrate and Citric Acid
NDC 62135-435 · Chartwell RX, LLC
Key facts
| Product NDC | 62135-435 |
|---|---|
| Proprietary name | Potassium Citrate and Citric Acid |
| Nonproprietary name | Potassium Citrate and Citric Acid |
| Substances | POTASSIUM CITRATE, CITRIC ACID MONOHYDRATE |
| Dosage form | SOLUTION |
| Route | ORAL |
| Labeler | Chartwell RX, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
| Marketing start | Dec 8, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: